BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
수요일, 9월 16

Anixa Biosciences Inc

ANIXNASDAQ
Trade with Public
Trade with Public
$2.67
-0.025-0.93%
마지막 업데이트: Sep 16, 11:02 AM
실적: Q3 2026 실적이 수 9월 9th에 시장 마감 후 발표되었습니다.
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Anixa Biosciences Financials

Anixa Biosciences (ANIX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Anixa Biosciences Q3 EPS $(0.08) Beats $(0.09) Estimate, Sales $0.00, Same YoY

Anixa Biosciences (NASDAQ:ANIX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 14.29 percent decrease over losses of $(0.07) per share
Benzinga Newsdesk

PRO
Anixa Biosciences Q2 EPS $(0.07) Beats $(0.09) Estimate

Anixa Biosciences (NASDAQ:ANIX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 22.22 percent increase over losses of $(0.09) per share from
Benzinga Newsdesk

PRO
Anixa Biosciences Q3 EPS $(0.07) Beats $(0.09) Estimate

Anixa Biosciences (NASDAQ:ANIX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 19.54 percent. This is a 30 percent increase over losses of $(0.10) per share from
Benzinga Newsdesk

PRO
Anixa Biosciences Highlights 2024 Achievements And 2025 Goals: Utilized $7M, Ended With $20M Cash, Presented Phase 1 Breast Cancer Vaccine Data With 70% Immune Response, Advanced Ovarian Cancer CAR-T Program, Preparing Phase 2 Study And Broader Cancer Vaccine Development

Benzinga Newsdesk

Recap: Anixa Biosciences Q1 Earnings

Benzinga Insights

Mid-Afternoon Market Update: Nasdaq Tumbles 150 Points; Knoll Shares Spike Higher

Toward the end of trading Monday, the Dow traded down 0.41% to 34,060.60 while the NASDAQ fell 1.08% to 13,900.17. The S&P also fell, dropping 0.59% to 4,160.89.
Lisa Levin

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved